Primary Site >> Pancreatic Cancer

Gene >> PYY

Journal: Neuropeptides. 1990 Feb;15(2):101-6.
Title: Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells.
Author: Ramo, O J|Balasubramaniam, A|Sheriff, S|Rogers, D H|McCullough, P J|Bell, R H Jr
PMID: 2080016
Journal: Surgery. 1995 Aug;118(2):229-35; discussion 235-6.
Title: Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels.
Author: Liu, C D|Slice, L W|Balasubramaniam, A|Walsh, J H|Newton, T R|Saxton, R E|McFadden, D W
PMID: 7638738
Journal: J Surg Res. 1995 Jun;58(6):707-12.
Title: Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1.
Author: Liu, C D|Balasubramaniam, A|Saxton, R E|Paiva, M|McFadden, D W
PMID: 7791350
Journal: Am J Surg. 1996 Jan;171(1):192-6.
Title: Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth.
Author: Liu, C D|Rongione, A J|Garvey, L|Balasubramaniam, A|McFadden, D W
PMID: 8554139
Journal: J Surg Res. 2000 Jan;88(1):23-5.
Title: Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth.
Author: Heisler, T|Towfigh, S|Simon, N|Liu, C|McFadden, D W
PMID: 10644462
Journal: J Gastrointest Surg. 2001 Mar-Apr;5(2):147-52.
Title: Synthetic peptide YY analog binds to a cell membrane receptor and delivers fluorescent dye to pancreatic cancer cells.
Author: Liu, C D|Kwan, D|Simon, N|McFadden, D W
PMID: 11331476
Journal: J Surg Res. 2002 Jun 1;105(1):65-8.
Title: Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor.
Author: Yu, A|Somasundar, P|Balsubramaniam, A|Rose, A T|Vona-Davis, L|McFadden, D W
PMID: 12069504
Journal: Peptides. 2007 Feb;28(2):334-8.
Title: PYY and the pancreas: inhibition of tumor growth and inflammation.
Author: Vona-Davis, Linda|McFadden, David W
PMID: 17194501
Journal: Rev Gastroenterol Peru. 2008 Apr-Jun;28(2):177-82.
Title: [Surgical treatment [corrected] of type 2 diabetes. Neuroendocrine basis in relation to three operated cases in Rebagliati Hospital].
Author: Rios Canturin, Pedro J|Perez Fernandez, Helmer|Rios Torres, Pedro
PMID: 18641782
Journal: Methods Mol Biol. 2009;512:377-94.
Title: Peptide YY mediates inhibition of tumor growth and inflammation.
Author: Alosi, Julie A|McFadden, David W
PMID: 19347290
Journal: Chin Med J (Engl). 2014;127(24):4235-42.
Title: Peptide tyrosine-tyrosine combined with its receptors exhibits an anti-cancer potential in pancreatic cancer MiaPaCa-2 cell.
Author: Li, Hongxia|Wang, Zhixin|Dong, Lei|Jiang, Jiong|Xu, Xinsen|Zhou, Lei|Wan, Yong
PMID: 25533827
Journal: Pancreatology. 2017 Jan - Feb;17(1):89-94.
Title: Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Author: Skrha, Jan|Busek, Petr|Uhrova, Jana|Hrabal, Petr|Kmochova, Klara|Laclav, Martin|Bunganic, Bohus|Fric, Premysl
PMID: 28027898